Zura Bio Limited (94E.F)

EUR 1.02

(5.7%)

Total Liabilities Summary of Zura Bio Limited

  • Zura Bio Limited's latest annual total liabilities in 2023 was 21.29 Million USD , up 43.69% from previous year.
  • Zura Bio Limited's latest quarterly total liabilities in 2024 Q2 was 17.43 Million USD , up 7.17% from previous quarter.
  • Zura Bio Limited reported annual total liabilities of 14.81 Million USD in 2022, up 18.18% from previous year.
  • Zura Bio Limited reported annual total liabilities of 12.53 Million USD in 2021, down 0.0% from previous year.
  • Zura Bio Limited reported quarterly total liabilities of 17.43 Million USD for 2024 Q2, up 7.17% from previous quarter.
  • Zura Bio Limited reported quarterly total liabilities of 22 Million USD for 2023 Q2, up 237.04% from previous quarter.

Annual Total Liabilities Chart of Zura Bio Limited (2023 - 2021)

Historical Annual Total Liabilities of Zura Bio Limited (2023 - 2021)

Year Total Liabilities Total Liabilities Growth
2023 21.29 Million USD 43.69%
2022 14.81 Million USD 18.18%
2021 12.53 Million USD 0.0%

Peer Total Liabilities Comparison of Zura Bio Limited

Name Total Liabilities Total Liabilities Difference
BioNTech SE 2.76 Billion EUR 99.229%
CureVac N.V. 271.53 Million EUR 92.159%
Biotest Aktiengesellschaft 945.4 Million EUR 97.748%
Biotest Aktiengesellschaft 945.4 Million EUR 97.748%
BRAIN Biotech AG 47.92 Million EUR 55.57%
Formycon AG 387.61 Million EUR 94.507%
Heidelberg Pharma AG 21.01 Million EUR -1.327%
Medigene AG 10.65 Million EUR -99.925%